Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 11.15
+0.35 (3.24%)
At close: Dec 5, 2025
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 4.67 billion as of December 5, 2025. Its market cap has decreased by -21.84% in one year.
Market Cap
4.67B
Enterprise Value
4.51B
Revenue
246.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
11.15
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has decreased from 5.10B to 4.67B, a decrease of -8.58%. That is a compound annual growth rate of -2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.67B | -15.14% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 189.73B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.34B |
| Center Laboratories | 28.11B |